EarningsQ2 2024 Earnings Report

Summit Therapeutics (SMMT) Q2 2024 Earnings Report

1 Followers

MX:SMMT Q2 2024 EPS Results

Actual EPS-$0.92

Consensus EPS-$1.14

Beat/MissBeat by +$0.22

One Year Ago EPS-$0.39

Actual Revenue$0.00

Expected Revenue$0.00

Beat/MissMet expectations

YoY Revenue Growth―

QuarterQ2 2024

Date08/06/2024

TimeBefore Open

Conference CallTuesday, August 6, 2024

MX:SMMT Upcoming Earnings

Summit Therapeutics's next earnings date is estimated for November 11, 2026, based on past reporting schedules.

MX:SMMT Q2 2024 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 11, 2026	2026 (Q3)	-5.17 / -	-5.701	―
Jul 23, 2026	2026 (Q2)	-5.04 / -5.15	-13.977	63.16% (+8.83)
Apr 30, 2026	2026 (Q1)	-4.95 / -4.41	-1.655	-166.67% (-2.76)
Feb 23, 2026	2025 (Q4)	-1.42 / -5.33	-1.471	-262.50% (-3.86)
Oct 20, 2025	2025 (Q3)	-1.54 / -5.70	-1.471	-287.50% (-4.23)
Aug 11, 2025	2025 (Q2)	-1.67 / -13.98	-0.92	-1420.00% (-13.06)
May 01, 2025	2025 (Q1)	-1.71 / -1.66	-1.103	-50.00% (-0.55)
Feb 24, 2025	2024 (Q4)	-1.51 / -1.47	-0.92	-60.00% (-0.55)
Oct 30, 2024	2024 (Q3)	-1.23 / -1.47	-0.552	-166.67% (-0.92)
Aug 06, 2024	2024 (Q2)	-1.14 / -0.92	-0.386	-138.10% (-0.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed